松尾英将

Last Update: 2020/07/08 17:11:45

Name(Kanji/Kana/Abecedarium Latinum)

松尾英将/マツオヒデマサ/Matuo, Hidemasa

Primary Affiliation(Org1/Job title)

Graduate Schools Medicine/Assistant Professor

Phone

Type	Number
Office	075-751-3938

Academic Organizations You are Affiliated to in Japan

Organization name(Japanese)	Organization name(English)
日本臨床衛生検査技師会	Japanese Association of Medical Technologists
日本血液学会	Japanese Society of Hematology
日本超音波医学会	Japan Society of Ultrasonics in Medicine
日本癌学会	Japanese Cancer Association
日本臨床検査医学会	Japanese Society of Laboratory Medicine

Academic Degree

Field(Japanese)	Field(English)	University(Japanese)	University(English)	Method
修士（人間健康科学）		京都大学
博士（人間健康科学）		京都大学

Undergraduate School / Major(s)

University(Japanese)	University(English)	Faculty(Japanese)	Faculty(English)	Major(s)(Japanese)	Major(s)(English)	Degree
京都大学		医学部保健学科検査技術科学専攻				卒業

High School

Highschool	Kana
京都教育大学附属高等学校

Work Experience

Period	Organization(Japanese)	Job title(Japanese)
2013/04/01-2013/07/31	京都大学医学部附属病院検査部	特定臨床検査技師
2013/08/01-2018/03/31	京都大学医学部附属病院検査部	臨床検査技師
2018/04/01-	京都大学大学院医学系研究科人間健康科学系専攻	助教

ORCID ID

https://orcid.org/0000-0002-7578-006X

researchmap URL

https://researchmap.jp/7000023069

Research Topics

(Japanese)
①急性骨髄性白血病の新規検査法及び治療法の開発 ②超音波を用いた関節リウマチとその合併症の病態評価法の確立
(English)
1. Investigation of novel examinations and treatment strategies for acute myeloid leukemia. 2. Establishment of the assessment method for rheumatoid arthritis and coexisting diseases using ultrasound.

Overview of the research

(Japanese)
臨床検体のゲノム解析及び細胞株やマウスモデルを用いた機能解析により、急性骨髄性白血病の新規検査法及び治療法の開発を行っている。また、超音波検査士としての経験を生かして、超音波を用いた関節リウマチとその合併症の病態評価法の確立を行っている。いずれの研究も、京都大学医学部附属病院の各部門・診療科(検査部、小児科、血液内科、リウマチセンター、呼吸器内科、放射線診断科など)との連携により進めている。
(English)
I am investigating novel examinations and treatment strategies for acute myeloid leukemia, by genomic analysis of clinical samples and functional analysis using cell lines and mouse models. As a certified sonographer, I am also studying to establish improved assessment methods for rheumatoid arthritis and coexisting diseases using ultrasound. Both studies are proceeding through collaboration with each department of Kyoto University Hospital (Department of Laboratory Medicine, Pediatrics, Hematology, Rheumatoid Arthritis Center, Respiratory Medicine, Diagnostic Imaging and Nuclear Medicine, etc.).

Fields of research (key words)

Key words(Japanese)	Key words(English)
臨床検査	Clinical examination
血液腫瘍	Hematological malignancies
ゲノム解析	Genomic analysis
予後因子	Prognostic factors
医用超音波	Medical ultrasound
関節リウマチ	Rheumatoid arthritis

Published Papers

Author	Author(Japanese)	Author(English)	Title	Title(Japanese)	Title(English)	Bibliography	Bibliography(Japanese)	Bibliography(English)	Publication date	Refereed paper	Language	Publishing type	Disclose
Noura M, Matsuo H, Koyama A, Adachi S, Masutani H	Noura M, Matsuo H, Koyama A, Adachi S, Masutani H	Noura M, Matsuo H, Koyama A, Adachi S, Masutani H	TXNIP induces growth arrest and enhances ABT263‐induced apoptosis in mixed‐lineage leukemia‐rearranged acute myeloid leukemia cells.	TXNIP induces growth arrest and enhances ABT263‐induced apoptosis in mixed‐lineage leukemia‐rearranged acute myeloid leukemia cells.	TXNIP induces growth arrest and enhances ABT263‐induced apoptosis in mixed‐lineage leukemia‐rearranged acute myeloid leukemia cells.	FEBS Open Bio. 2020 Jun 8. doi: 10.1002/2211-5463.12908. Online ahead of print.	FEBS Open Bio. 2020 Jun 8. doi: 10.1002/2211-5463.12908. Online ahead of print.	FEBS Open Bio. 2020 Jun 8. doi: 10.1002/2211-5463.12908. Online ahead of print.	2020	Refereed		Research paper(scientific journal)	Disclose to all
Matsuo H, Imamura A, Shimizu M, Inagaki M, Tsuji Y, Nakabo S, Hashimoto M, Ito H, Tanaka S, Mimori T, Fujii Y	Matsuo H, Imamura A, Shimizu M, Inagaki M, Tsuji Y, Nakabo S, Hashimoto M, Ito H, Tanaka S, Mimori T, Fujii Y	Matsuo H, Imamura A, Shimizu M, Inagaki M, Tsuji Y, Nakabo S, Hashimoto M, Ito H, Tanaka S, Mimori T, Fujii Y	Prediction of recurrence and remission using superb microvascular imaging in rheumatoid arthritis.	Prediction of recurrence and remission using superb microvascular imaging in rheumatoid arthritis.	Prediction of recurrence and remission using superb microvascular imaging in rheumatoid arthritis.	J Med Ultrason (2001). 2020 Jan;47(1):131-138.	J Med Ultrason (2001). 2020 Jan;47(1):131-138.	J Med Ultrason (2001). 2020 Jan;47(1):131-138.	2020/01	Refereed	English	Research paper(scientific journal)	Disclose to all
Shiba N, Yoshida K, Hara Y, Yamato G, Shiraishi Y, Matsuo H, Okuno Y, Chiba K, Tanaka H, Kaburagi T, Takeuchi M, Ohki K, Sanada M, Okubo J, Tomizawa D, Taki T, Shimada A, Sotomatsu M, Horibe K, Taga T, Adachi S, Tawa A, Miyano S, Ogawa S, Hayashi Y	Shiba N, Yoshida K, Hara Y, Yamato G, Shiraishi Y, Matsuo H, Okuno Y, Chiba K, Tanaka H, Kaburagi T, Takeuchi M, Ohki K, Sanada M, Okubo J, Tomizawa D, Taki T, Shimada A, Sotomatsu M, Horibe K, Taga T, Adachi S, Tawa A, Miyano S, Ogawa S, Hayashi Y	Shiba N, Yoshida K, Hara Y, Yamato G, Shiraishi Y, Matsuo H, Okuno Y, Chiba K, Tanaka H, Kaburagi T, Takeuchi M, Ohki K, Sanada M, Okubo J, Tomizawa D, Taki T, Shimada A, Sotomatsu M, Horibe K, Taga T, Adachi S, Tawa A, Miyano S, Ogawa S, Hayashi Y	Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.	Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.	Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.	Blood Adv. 2019 Oct 22;3(20):3157-3169.	Blood Adv. 2019 Oct 22;3(20):3157-3169.	Blood Adv. 2019 Oct 22;3(20):3157-3169.	2019/10	Refereed	English	Research paper(scientific journal)	Disclose to all
Saito Y, Sawa D, Kinoshita M, Yamada A, Kamimura S, Suekane A, Ogoh H, Matsuo H, Adachi S, Taga T, Tomizawa D, Osato M, Soga T, Morishita K, Moritake H.	Saito Y, Sawa D, Kinoshita M, Yamada A, Kamimura S, Suekane A, Ogoh H, Matsuo H, Adachi S, Taga T, Tomizawa D, Osato M, Soga T, Morishita K, Moritake H	Saito Y, Sawa D, Kinoshita M, Yamada A, Kamimura S, Suekane A, Ogoh H, Matsuo H, Adachi S, Taga T, Tomizawa D, Osato M, Soga T, Morishita K, Moritake H.	EVI1 triggers metabolic reprogramming associated with leukemogenesis and increases sensitivity to L-asparaginase.	EVI1 triggers metabolic reprogramming associated with leukemogenesis and increases sensitivity to L-asparaginase.	EVI1 triggers metabolic reprogramming associated with leukemogenesis and increases sensitivity to L-asparaginase.	Haematologica. 2019 Oct 24:haematol.2019.225953. Online ahead of print.	Haematologica. 2019 Oct 24:haematol.2019.225953. Online ahead of print.	Haematologica. 2019 Oct 24:haematol.2019.225953. Online ahead of print.	2019	Refereed	English	Research paper(scientific journal)	Disclose to all
Matsuo H, Yoshida K, Fukumura K, Nakatani K, Noguchi Y, Takasaki S, Noura M, Shiozawa Y, Shiraishi Y, Chiba K, Tanaka H, Okada A, Nannya Y, Takeda J, Ueno H, Shiba N, Yamato G, Handa H, Ono Y, Hiramoto N, Ishikawa T, Usuki K, Ishiyama K, Miyawaki S, Itonaga H, Miyazaki Y, Kawamura M, Yamaguchi H, Kiyokawa N, Tomizawa D, Taga T, Tawa A, Hayashi Y, Mano H, Miyano S, Kamikubo Y, Ogawa S, Adachi S	Matsuo H, Yoshida K, Fukumura K, Nakatani K, Noguchi Y, Takasaki S, Noura M, Shiozawa Y, Shiraishi Y, Chiba K, Tanaka H, Okada A, Nannya Y, Takeda J, Ueno H, Shiba N, Yamato G, Handa H, Ono Y, Hiramoto N, Ishikawa T, Usuki K, Ishiyama K, Miyawaki S, Itonaga H, Miyazaki Y, Kawamura M, Yamaguchi H, Kiyokawa N, Tomizawa D, Taga T, Tawa A, Hayashi Y, Mano H, Miyano S, Kamikubo Y, Ogawa S, Adachi S	Matsuo H, Yoshida K, Fukumura K, Nakatani K, Noguchi Y, Takasaki S, Noura M, Shiozawa Y, Shiraishi Y, Chiba K, Tanaka H, Okada A, Nannya Y, Takeda J, Ueno H, Shiba N, Yamato G, Handa H, Ono Y, Hiramoto N, Ishikawa T, Usuki K, Ishiyama K, Miyawaki S, Itonaga H, Miyazaki Y, Kawamura M, Yamaguchi H, Kiyokawa N, Tomizawa D, Taga T, Tawa A, Hayashi Y, Mano H, Miyano S, Kamikubo Y, Ogawa S, Adachi S	Recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia.	Recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia.	Recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia.	Blood Adv. 2018 Nov 13;2(21):2879-2889.	Blood Adv. 2018 Nov 13;2(21):2879-2889.	Blood Adv. 2018 Nov 13;2(21):2879-2889.	2018/11	Refereed	English	Research paper(scientific journal)	Disclose to all
Matsuo H, Handa T, Tsuchiya M, Kubo T, Yoshizawa A, Nakayama Y, Shiga S, Hitomi T, Adachi S, Date H, Hirai T, Ichiyama S	Matsuo H, Handa T, Tsuchiya M, Kubo T, Yoshizawa A, Nakayama Y, Shiga S, Hitomi T, Adachi S, Date H, Hirai T, Ichiyama S	Matsuo H, Handa T, Tsuchiya M, Kubo T, Yoshizawa A, Nakayama Y, Shiga S, Hitomi T, Adachi S, Date H, Hirai T, Ichiyama S	Progressive Restrictive Ventilatory Impairment in Idiopathic Diffuse Pulmonary Ossification.	Progressive Restrictive Ventilatory Impairment in Idiopathic Diffuse Pulmonary Ossification.	Progressive Restrictive Ventilatory Impairment in Idiopathic Diffuse Pulmonary Ossification.	Intern Med. 2018 Jun 1;57(11):1631-1636.	Intern Med. 2018 Jun 1;57(11):1631-1636.	Intern Med. 2018 Jun 1;57(11):1631-1636.	2018/06	Refereed	English	Research paper(scientific journal)	Disclose to all
Matsuo H, Iijima-Yamashita Y, Yamada M, Deguchi T, Kiyokawa N, Shimada A, Tawa A, Tomizawa D, Taga T, Kinoshita A, Adachi S, Horibe K	Matsuo H, Iijima-Yamashita Y, Yamada M, Deguchi T, Kiyokawa N, Shimada A, Tawa A, Tomizawa D, Taga T, Kinoshita A, Adachi S, Horibe K		Monitoring of fusion gene transcripts to predict relapses in pediatric acute myeloid leukemia.	Monitoring of fusion gene transcripts to predict relapses in pediatric acute myeloid leukemia.	Monitoring of fusion gene transcripts to predict relapses in pediatric acute myeloid leukemia.	Pediatr Int. 2018 Jan;60(1):41-46.	Pediatr Int. 2018 Jan;60(1):41-46.	Pediatr Int. 2018 Jan;60(1):41-46.	2018/01	Refereed	English	Research paper(scientific journal)	Disclose to all
Iijima-Yamashita Y, Matsuo H, Yamada M, Deguchi T, Kiyokawa N, Shimada A, Tawa A, Takahashi H, Tomizawa D, Taga T, Kinoshita A, Adachi S, Horibe K, *equal contribution.	Iijima-Yamashita Y, Matsuo H, Yamada M, Deguchi T, Kiyokawa N, Shimada A, Tawa A, Takahashi H, Tomizawa D, Taga T, Kinoshita A, Adachi S, Horibe K, *equal contribution.	Iijima-Yamashita Y, Matsuo H, Yamada M, Deguchi T, Kiyokawa N, Shimada A, Tawa A, Takahashi H, Tomizawa D, Taga T, Kinoshita A, Adachi S, Horibe K, *equal contribution.	Multiplex fusion gene testing in pediatric acute myeloid leukemia.	Multiplex fusion gene testing in pediatric acute myeloid leukemia.	Multiplex fusion gene testing in pediatric acute myeloid leukemia.	Pediatr Int. 2018 Jan;60(1):47-51.	Pediatr Int. 2018 Jan;60(1):47-51.	Pediatr Int. 2018 Jan;60(1):47-51.	2018/01	Refereed	English	Research paper(scientific journal)	Disclose to all
Morita K, Noura M, Tokushige C, Maeda S, Kiyose H, Kashiwazaki G, Taniguchi J, Bando T, Yoshida K, Ozaki T, Matsuo H, Ogawa S, Liu PP, Nakahata T, Sugiyama H, Adachi S, Kamikubo Y	Morita K, Noura M, Tokushige C, Maeda S, Kiyose H, Kashiwazaki G, Taniguchi J, Bando T, Yoshida K, Ozaki T, Matsuo H, Ogawa S, Liu PP, Nakahata T, Sugiyama H, Adachi S, Kamikubo Y	Morita K, Noura M, Tokushige C, Maeda S, Kiyose H, Kashiwazaki G, Taniguchi J, Bando T, Yoshida K, Ozaki T, Matsuo H, Ogawa S, Liu PP, Nakahata T, Sugiyama H, Adachi S, Kamikubo Y	Autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells.	Autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells.	Autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells.	Sci Rep. 2017 Nov 30;7(1):16604.	Sci Rep. 2017 Nov 30;7(1):16604.	Sci Rep. 2017 Nov 30;7(1):16604.	2017/11	Refereed	English	Research paper(scientific journal)	Disclose to all
Nakayama H, Tomizawa D, Tanaka S, Iwamoto S, Shimada A, Saito AM, Yamashita Y, Moritake H, Terui K, Taga T, Matsuo H, Kosaka Y, Koh K, Hosoi H, Kurosawa H, Isoyama K, Horibe K, Mizutani S, Adachi S	Nakayama H, Tomizawa D, Tanaka S, Iwamoto S, Shimada A, Saito AM, Yamashita Y, Moritake H, Terui K, Taga T, Matsuo H, Kosaka Y, Koh K, Hosoi H, Kurosawa H, Isoyama K, Horibe K, Mizutani S, Adachi S		Fludarabine, cytarabine, G-CSF and idarubicin for children with relapsed AML.	Fludarabine, cytarabine, G-CSF and idarubicin for children with relapsed AML.	Fludarabine, cytarabine, G-CSF and idarubicin for children with relapsed AML.	Pediatr Int. 2017 Oct;59(10):1046-1052.	Pediatr Int. 2017 Oct;59(10):1046-1052.	Pediatr Int. 2017 Oct;59(10):1046-1052.	2017/10	Refereed	English	Research paper(scientific journal)	Disclose to all
Matsuo H, Shiga S, Imai T, Kamikubo Y, Toki T, Terui K, Ito E, Adachi S	Matsuo H, Shiga S, Imai T, Kamikubo Y, Toki T, Terui K, Ito E, Adachi S	Matsuo H, Shiga S, Imai T, Kamikubo Y, Toki T, Terui K, Ito E, Adachi S	Purification of leukemic blast cells from blood smears using laser microdissection.	Purification of leukemic blast cells from blood smears using laser microdissection.	Purification of leukemic blast cells from blood smears using laser microdissection.	Int J Hematol. 2017 Jul;106(1):55-59.	Int J Hematol. 2017 Jul;106(1):55-59.	Int J Hematol. 2017 Jul;106(1):55-59.	2017/07	Refereed	English	Research paper(scientific journal)	Disclose to all
Morita K, Suzuki K, Maeda S, Matsuo A, Mitsuda Y, Tokushige C, Kashiwazaki G, Taniguchi J, Maeda R, Noura M, Hirata M, Kataoka T, Yano A, Yamada Y, Kiyose H, Tokumasu M, Matsuo H, Tanaka S, Okuno Y, Muto M, Naka K, Ito K, Kitamura T, Kaneda Y, Liu PP, Bando T, Adachi S, Sugiyama H, Kamikubo Y	Morita K, Suzuki K, Maeda S, Matsuo A, Mitsuda Y, Tokushige C, Kashiwazaki G, Taniguchi J, Maeda R, Noura M, Hirata M, Kataoka T, Yano A, Yamada Y, Kiyose H, Tokumasu M, Matsuo H, Tanaka S, Okuno Y, Muto M, Naka K, Ito K, Kitamura T, Kaneda Y, Liu PP, Bando T, Adachi S, Sugiyama H, Kamikubo Y	Morita K, Suzuki K, Maeda S, Matsuo A, Mitsuda Y, Tokushige C, Kashiwazaki G, Taniguchi J, Maeda R, Noura M, Hirata M, Kataoka T, Yano A, Yamada Y, Kiyose H, Tokumasu M, Matsuo H, Tanaka S, Okuno Y, Muto M, Naka K, Ito K, Kitamura T, Kaneda Y, Liu PP, Bando T, Adachi S, Sugiyama H, Kamikubo Y	Genetic regulation of the RUNX transcription factor family has antitumor effects.	Genetic regulation of the RUNX transcription factor family has antitumor effects.	Genetic regulation of the RUNX transcription factor family has antitumor effects.	J Clin Invest. 2017 Jun 30;127(7):2815-2828.	J Clin Invest. 2017 Jun 30;127(7):2815-2828.	J Clin Invest. 2017 Jun 30;127(7):2815-2828.	2017/06	Refereed	English	Research paper(scientific journal)	Disclose to all
Matsuo H, Nakamura N, Tomizawa D, Saito AM, Kiyokawa N, Horibe K, Nishinaka-Arai Y, Tokumasu M, Itoh H, Kamikubo Y, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Tanaka S, Adachi S	Matsuo H, Nakamura N, Tomizawa D, Saito AM, Kiyokawa N, Horibe K, Nishinaka-Arai Y, Tokumasu M, Itoh H, Kamikubo Y, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Tanaka S, Adachi S	Matsuo H, Nakamura N, Tomizawa D, Saito AM, Kiyokawa N, Horibe K, Nishinaka-Arai Y, Tokumasu M, Itoh H, Kamikubo Y, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Tanaka S, Adachi S	CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group.	CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group.	CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group.	Pediatr Blood Cancer. 2016 Aug;63(8):1394-9.	Pediatr Blood Cancer. 2016 Aug;63(8):1394-9.	Pediatr Blood Cancer. 2016 Aug;63(8):1394-9.	2016/08	Refereed	English	Research paper(scientific journal)	Disclose to all
Matsuo H, Itoh H, Kitamura N, Kamikubo Y, Higuchi T, Shiga S, Ichiyama S, Kondo T, Takaori-Kondo A, Adachi S	Matsuo H, Itoh H, Kitamura N, Kamikubo Y, Higuchi T, Shiga S, Ichiyama S, Kondo T, Takaori-Kondo A, Adachi S	Matsuo H, Itoh H, Kitamura N, Kamikubo Y, Higuchi T, Shiga S, Ichiyama S, Kondo T, Takaori-Kondo A, Adachi S	Intravenous immunoglobulin enhances the killing activity and autophagy of neutrophils isolated from immunocompromised patients against multidrug-resistant bacteria.	Intravenous immunoglobulin enhances the killing activity and autophagy of neutrophils isolated from immunocompromised patients against multidrug-resistant bacteria.	Intravenous immunoglobulin enhances the killing activity and autophagy of neutrophils isolated from immunocompromised patients against multidrug-resistant bacteria.	Biochem Biophys Res Commun. 2015 Aug 14;464(1):94-9.	Biochem Biophys Res Commun. 2015 Aug 14;464(1):94-9.	Biochem Biophys Res Commun. 2015 Aug 14;464(1):94-9.	2015/08	Refereed	English	Research paper(scientific journal)	Disclose to all
Itoh H, Matsuo H, Kitamura N, Yamamoto S, Higuchi T, Takematsu H, Kamikubo Y, Kondo T, Yamashita K, Sasada M, Takaori-Kondo A, Adachi S, *equal contribution.	Itoh H, Matsuo H, Kitamura N, Yamamoto S, Higuchi T, Takematsu H, Kamikubo Y, Kondo T, Yamashita K, Sasada M, Takaori-Kondo A, Adachi S, *equal contribution.	Itoh H, Matsuo H, Kitamura N, Yamamoto S, Higuchi T, Takematsu H, Kamikubo Y, Kondo T, Yamashita K, Sasada M, Takaori-Kondo A, Adachi S, *equal contribution.	Enhancement of neutrophil autophagy by an IVIG preparation against multidrug-resistant bacteria as well as drug-sensitive strains.	Enhancement of neutrophil autophagy by an IVIG preparation against multidrug-resistant bacteria as well as drug-sensitive strains.	Enhancement of neutrophil autophagy by an IVIG preparation against multidrug-resistant bacteria as well as drug-sensitive strains.	J Leukoc Biol. 2015 Jul;98(1):107-17.	J Leukoc Biol. 2015 Jul;98(1):107-17.	J Leukoc Biol. 2015 Jul;98(1):107-17.	2015/07	Refereed	English	Research paper(scientific journal)	Disclose to all
Matsuo H, Goyama S, Kamikubo Y, Adachi S	Matsuo H, Goyama S, Kamikubo Y, Adachi S	Matsuo H, Goyama S, Kamikubo Y, Adachi S	The subtype-specific features of EVI1 and PRDM16 in acute myeloid leukemia.	The subtype-specific features of EVI1 and PRDM16 in acute myeloid leukemia.	The subtype-specific features of EVI1 and PRDM16 in acute myeloid leukemia.	Haematologica. 2015 Mar;100(3):e116-7.	Haematologica. 2015 Mar;100(3):e116-7.	Haematologica. 2015 Mar;100(3):e116-7.	2015/03	Refereed	English	Research paper(scientific journal)	Disclose to all
Matsuo H, Kajihara M, Tomizawa D, Watanabe T, Saito AM, Fujimoto J, Horibe K, Kodama K, Tokumasu M, Itoh H, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Shiba N, Ohki K, Hayashi Y, Yamashita Y, Shimada A, Tanaka S, Adachi S	Matsuo H, Kajihara M, Tomizawa D, Watanabe T, Saito AM, Fujimoto J, Horibe K, Kodama K, Tokumasu M, Itoh H, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Shiba N, Ohki K, Hayashi Y, Yamashita Y, Shimada A, Tanaka S, Adachi S	Matsuo H, Kajihara M, Tomizawa D, Watanabe T, Saito AM, Fujimoto J, Horibe K, Kodama K, Tokumasu M, Itoh H, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Shiba N, Ohki K, Hayashi Y, Yamashita Y, Shimada A, Tanaka S, Adachi S	EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemia.	EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemia.	EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemia.	Haematologica. 2014 Nov;99(11):e225-7.	Haematologica. 2014 Nov;99(11):e225-7.	Haematologica. 2014 Nov;99(11):e225-7.	2014/11	Refereed	English	Research paper(scientific journal)	Disclose to all
Kinoshita A, Miyachi H, Matsushita H, Yabe M, Taki T, Watanabe T, Saito AM, Tomizawa D, Taga T, Takahashi H, Matsuo H, Kodama K, Ohki K, Hayashi Y, Tawa A, Horibe K, Adachi S	Kinoshita A, Miyachi H, Matsushita H, Yabe M, Taki T, Watanabe T, Saito AM, Tomizawa D, Taga T, Takahashi H, Matsuo H, Kodama K, Ohki K, Hayashi Y, Tawa A, Horibe K, Adachi S	Kinoshita A, Miyachi H, Matsushita H, Yabe M, Taki T, Watanabe T, Saito AM, Tomizawa D, Taga T, Takahashi H, Matsuo H, Kodama K, Ohki K, Hayashi Y, Tawa A, Horibe K, Adachi S	Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group.	Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group.	Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group.	Br J Haematol. 2014 Oct;167(1):80-6.	Br J Haematol. 2014 Oct;167(1):80-6.	Br J Haematol. 2014 Oct;167(1):80-6.	2014/10	Refereed	English	Research paper(scientific journal)	Disclose to all
Matsuo H, Kajihara M, Tomizawa D, Watanabe T, Saito AM, Fujimoto J, Horibe K, Kodama K, Tokumasu M, Itoh H, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Tanaka S, Adachi S	Matsuo H, Kajihara M, Tomizawa D, Watanabe T, Saito AM, Fujimoto J, Horibe K, Kodama K, Tokumasu M, Itoh H, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Tanaka S, Adachi S	Matsuo H, Kajihara M, Tomizawa D, Watanabe T, Saito AM, Fujimoto J, Horibe K, Kodama K, Tokumasu M, Itoh H, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Tanaka S, Adachi S	Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group.	Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group.	Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group.	Blood Cancer J. 2014 Jul 11;4(7):e226.	Blood Cancer J. 2014 Jul 11;4(7):e226.	Blood Cancer J. 2014 Jul 11;4(7):e226.	2014/07	Refereed	English	Research paper(scientific journal)	Disclose to all
<< < > >> Title language:

Misc

Author	Author(Japanese)	Title	Title(Japanese)	Bibliography	Bibliography(Japanese)	Bibliography(English)	Publication date	Language	Publishing type	Disclose
松尾英将	松尾英将	Introduce My Article	Introduce My Article	臨床血液, 60, 3, 256	臨床血液, 60, 3, 256	, 60, 3, 256	2019	Japanese	Introduction and explanation (scientific journal)	Disclose to all
松尾英将	松尾英将	国際学会に行こう！「はじめてで不安」「英語に自信がない」というあなたのために第3回発表をしよう！＜準備編＞	国際学会に行こう！「はじめてで不安」「英語に自信がない」というあなたのために第3回発表をしよう！＜準備編＞	Medical Technology (医歯薬出版), 44, 1, 99-103	Medical Technology (医歯薬出版), 44, 1, 99-103	, 44, 1, 99-103	2016	Japanese	Introduction and explanation (commerce magazine)	Disclose to all
松尾英将	松尾英将	国際学会に行こう！「はじめてで不安」「英語に自信がない」というあなたのために第4回発表をしよう！＜当日編＞	国際学会に行こう！「はじめてで不安」「英語に自信がない」というあなたのために第4回発表をしよう！＜当日編＞	Medical Technology (医歯薬出版), 44, 2, 203-208	Medical Technology (医歯薬出版), 44, 2, 203-208	, 44, 2, 203-208	2016	Japanese	Introduction and explanation (commerce magazine)	Disclose to all
大﨑博之, 菊地良介, 松尾英将, 岡田光貴, 井垣歩, 坂本秀生	大﨑博之, 菊地良介, 松尾英将, 岡田光貴, 井垣歩, 坂本秀生	Special Report 第32回世界医学検査学会国際学生フォーラム	Special Report 第32回世界医学検査学会国際学生フォーラム	Medical Technology (医歯薬出版), 44, 12, 1332-1333	Medical Technology (医歯薬出版), 44, 12, 1332-1333	, 44, 12, 1332-1333	2016	Japanese	Meeting report etc.	Disclose to all
松尾英将	松尾英将	「遺伝子分析科学認定士制度」第5回一級認定試験を受験・合格して	「遺伝子分析科学認定士制度」第5回一級認定試験を受験・合格して	日本臨床検査同学院通信, 41, 201	日本臨床検査同学院通信, 41, 201	, 41, 201	2016	Japanese	Other article	Disclose to all
松尾英将, 足立壯一	松尾英将, 足立壯一	小児急性骨髄性白血病の分子的理解と臨床応用	小児急性骨髄性白血病の分子的理解と臨床応用	血液フロンティア (医薬ジャーナル社), 26, 11, 1513-1521	血液フロンティア (医薬ジャーナル社), 26, 11, 1513-1521	, 26, 11, 1513-1521	2016	Japanese	Introduction and explanation (commerce magazine)	Disclose to all
松尾英将, 足立壯一	松尾英将, 足立壯一	造血器腫瘍の発症、治療におけるオートファジーの意義	造血器腫瘍の発症、治療におけるオートファジーの意義	血液内科 (科学評論社), 71, 6, 748-754	血液内科 (科学評論社), 71, 6, 748-754	, 71, 6, 748-754	2015	Japanese	Introduction and explanation (commerce magazine)	Disclose to all
松尾英将, 坂本秀生	松尾英将, 坂本秀生	今知りたい臨床検査技師の国際資格制度：ASCP International Certification―最新情報から受験体験記まで―	今知りたい臨床検査技師の国際資格制度：ASCP International Certification―最新情報から受験体験記まで―	Medical Technology (医歯薬出版), 43, 4, 407-415	Medical Technology (医歯薬出版), 43, 4, 407-415	, 43, 4, 407-415	2015	Japanese	Introduction and explanation (commerce magazine)	Disclose to all
松尾英将	松尾英将	人間健康科学を学んで	人間健康科学を学んで	京都大学大学案内「知と自由への誘い 2014」, 53	京都大学大学案内「知と自由への誘い 2014」, 53	, 53	2014	Japanese	Other article	Disclose to all
松尾英将	松尾英将	アメリカ臨床検査技師の国際資格International Medical Technologist, MT(ASCPi)取得に挑戦して	アメリカ臨床検査技師の国際資格International Medical Technologist, MT(ASCPi)取得に挑戦して	京都大学大学院医学研究科人間健康科学系専攻紀要 : 健康科学 : health science, 9, 52-54	京都大学大学院医学研究科人間健康科学系専攻紀要 : 健康科学 : health science, 9, 52-54	, 9, 52-54	2014	Japanese	Introduction and explanation (bulletin of university, research institution)	Disclose to all
松尾英将	松尾英将	米国臨床検査技師の国際資格:International Medical Technologist, MT(ASCPi)を取得して	米国臨床検査技師の国際資格:International Medical Technologist, MT(ASCPi)を取得して	THE MEDICAL & TEST JOURNAL (じほう), 1242, 5	THE MEDICAL & TEST JOURNAL (じほう), 1242, 5	, 1242, 5	2013	Japanese	Introduction and explanation (commerce magazine)	Disclose to all
松尾英将, 足立壯一	松尾英将, 足立壯一	DISCアポトーシス複合体によるネクローシス抑制	DISCアポトーシス複合体によるネクローシス抑制	血液内科 (科学評論社), 64, 6, 767-774	血液内科 (科学評論社), 64, 6, 767-774	, 64, 6, 767-774	2012	Japanese	Introduction and explanation (commerce magazine)	Disclose to all
<< < > >> Title language:

Conference Activities & Talks

Title	Title(Japanese)	Conference	Conference(Japanese)	Date	Assortment	Disclose
Clinical Features of Pediatric Acute Myeloid Leukemia with TP53 and CDKN2A/2B Copy Number Alterations.	Clinical Features of Pediatric Acute Myeloid Leukemia with TP53 and CDKN2A/2B Copy Number Alterations.	61st ASH Annual Meeting & Exposition	61st ASH Annual Meeting & Exposition	2019/12		Disclose to all
Recurrent gene mutations in pediatric AML patients by targeted sequencing ―the JCCG study, JPLSG AML-05―.	Recurrent gene mutations in pediatric AML patients by targeted sequencing ―the JCCG study, JPLSG AML-05―.	61st ASH Annual Meeting & Exposition	61st ASH Annual Meeting & Exposition	2019/12		Disclose to all
Coexistence and prognostic significance of EVI1 expression and driver mutations in KMT2A-rearranged acute myeloid leukemia.	Coexistence and prognostic significance of EVI1 expression and driver mutations in KMT2A-rearranged acute myeloid leukemia.	61st ASH Annual Meeting & Exposition	61st ASH Annual Meeting & Exposition	2019/12		Disclose to all
関節リウマチ患者の予後予測に最適な関節エコー検査部位およびカットオフ値の検討	関節リウマチ患者の予後予測に最適な関節エコー検査部位およびカットオフ値の検討	第66回日本臨床検査医学会学術集会	第66回日本臨床検査医学会学術集会	2019/11		Disclose to all
Clinical significances of patients with KMT2C and PHF6 mutations in pediatric acute myeloid leukemia.	Clinical significances of patients with KMT2C and PHF6 mutations in pediatric acute myeloid leukemia.	第61回日本小児血液・がん学会学術集会	第61回日本小児血液・がん学会学術集会	2019/11		Disclose to all
Clinical and molecular characterization of pediatric acute myeloid leukemia with TP53 alterations.	Clinical and molecular characterization of pediatric acute myeloid leukemia with TP53 alterations.	第61回日本小児血液・がん学会学術集会	第61回日本小児血液・がん学会学術集会	2019/11		Disclose to all
CDK4/6 and autophagy inhibitors synergistically induce apoptosis in t(8;21) AML cells.	CDK4/6 and autophagy inhibitors synergistically induce apoptosis in t(8;21) AML cells.	第81回日本血液学会学術集会	第81回日本血液学会学術集会	2019/10		Disclose to all
Recurrent gene mutations in pediatric AML by targeted sequencing using a 343-gene custom panel.	Recurrent gene mutations in pediatric AML by targeted sequencing using a 343-gene custom panel.	第81回日本血液学会学術集会	第81回日本血液学会学術集会	2019/10		Disclose to all
小児MLL再構成急性骨髄性白血病(AML)の網羅的遺伝子解析による新規予後因子同定	小児MLL再構成急性骨髄性白血病(AML)の網羅的遺伝子解析による新規予後因子同定	第38回京都がん研究会	第38回京都がん研究会	2019/10		Disclose to all
Pivotal role of DPYSL2A in KLF4-mediated monocytic differentiation of acute myeloid leukemia cells.	Pivotal role of DPYSL2A in KLF4-mediated monocytic differentiation of acute myeloid leukemia cells.	第78回日本癌学会学術総会	第78回日本癌学会学術総会	2019/09		Disclose to all
KIT regulator "RUNX1" as a novel therapeutic target in human mast-cell diseases.	KIT regulator "RUNX1" as a novel therapeutic target in human mast-cell diseases.	第78回日本癌学会学術総会	第78回日本癌学会学術総会	2019/09		Disclose to all
Targeting RUNX1-TRIM24/BCL11A axis through CROX (Cluster Regulation of RUNX) as a therapeutic strategy for neuroblastoma.	Targeting RUNX1-TRIM24/BCL11A axis through CROX (Cluster Regulation of RUNX) as a therapeutic strategy for neuroblastoma.	第78回日本癌学会学術総会	第78回日本癌学会学術総会	2019/09		Disclose to all
The combinatorial Histone Acetyltransferases (HATs) inhibition as a novel therapeutic strategy for KRAS enhanced cancers.	The combinatorial Histone Acetyltransferases (HATs) inhibition as a novel therapeutic strategy for KRAS enhanced cancers.	第78回日本癌学会学術総会	第78回日本癌学会学術総会	2019/09		Disclose to all
The importance of pan-RUNX and CROX (Cluster Regulation of RUNX) therapeutic approach for gastrointestinal cancers.	The importance of pan-RUNX and CROX (Cluster Regulation of RUNX) therapeutic approach for gastrointestinal cancers.	第78回日本癌学会学術総会	第78回日本癌学会学術総会	2019/09		Disclose to all
Apoptotic cell death induced by p300/CBPSurvivin regulation in triple negative breast cancer.	Apoptotic cell death induced by p300/CBPSurvivin regulation in triple negative breast cancer.	第78回日本癌学会学術総会	第78回日本癌学会学術総会	2019/09		Disclose to all
Induction of cell death in Malignant rhabdoid tumor (MRT) cells through regulating RUNX-Survivin Axis.	Induction of cell death in Malignant rhabdoid tumor (MRT) cells through regulating RUNX-Survivin Axis.	第78回日本癌学会学術総会	第78回日本癌学会学術総会	2019/09		Disclose to all
Identification of RUNX1-NFATc2 axis as a novel target for overcoming drug-resistant APL.	Identification of RUNX1-NFATc2 axis as a novel target for overcoming drug-resistant APL.	第78回日本癌学会学術総会	第78回日本癌学会学術総会	2019/09		Disclose to all
Induction of autophagy by CDK4/6 inhibition in t(8;21) acute myeloid leukemia cells.	Induction of autophagy by CDK4/6 inhibition in t(8;21) acute myeloid leukemia cells.	第78回日本癌学会学術総会	第78回日本癌学会学術総会	2019/09		Disclose to all
「疑似髄液」による細胞数算定検査の学内実習の試み	「疑似髄液」による細胞数算定検査の学内実習の試み	第14回日本臨床検査学教育学会学術大会	第14回日本臨床検査学教育学会学術大会	2019/08		Disclose to all
ddPCRを用いた小児APLの微小残存病変の解析：AML-P17付随研究	ddPCRを用いた小児APLの微小残存病変の解析：AML-P17付随研究	2019年度第１回JCCG血液腫瘍分科会（JPLSG）全体会議・合同班会議	2019年度第１回JCCG血液腫瘍分科会（JPLSG）全体会議・合同班会議	2019/06		Disclose to all
関節リウマチ患者の再燃予測に有用な関節エコー検査部位の探索	関節リウマチ患者の再燃予測に有用な関節エコー検査部位の探索	第92回日本超音波医学会学術集会	第92回日本超音波医学会学術集会	2019/05		Disclose to all
Recurrent genomic aberrations of D-type cyclins are therapeutic targets of CDK4/6 inhibitors in t(8;21) and MLL-rearranged acute myeloid leukemia.	Recurrent genomic aberrations of D-type cyclins are therapeutic targets of CDK4/6 inhibitors in t(8;21) and MLL-rearranged acute myeloid leukemia.	60th ASH Annual Meeting and Exposition	60th ASH Annual Meeting and Exposition	2018/12		Disclose to all
Comprehensive Analysis of 343 Genes Using Targeted Sequencing Panel By Next-Generation Sequencer in 77 Pediatric AML Patients with Normal and Complex Karyotypes: Jccg Study, JPLSG AML-05.	Comprehensive Analysis of 343 Genes Using Targeted Sequencing Panel By Next-Generation Sequencer in 77 Pediatric AML Patients with Normal and Complex Karyotypes: Jccg Study, JPLSG AML-05.	60th ASH Annual Meeting and Exposition	60th ASH Annual Meeting and Exposition	2018/12		Disclose to all
The detection of minor clones with somatic KIT D816V mutations in pediatric de novo AML	The detection of minor clones with somatic KIT D816V mutations in pediatric de novo AML	第80回日本血液学会学術集会	第80回日本血液学会学術集会	2018/10		Disclose to all
Identification of recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia.	Identification of recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia.	第80回日本血液学会学術集会	第80回日本血液学会学術集会	2018/10		Disclose to all
Landscape and prognostic significance of coexisting mutations in pediatric MLL-rearranged AML.	Landscape and prognostic significance of coexisting mutations in pediatric MLL-rearranged AML.	The 33rd World Congress of Biomedical Laboratory Science (IFBLS)	The 33rd World Congress of Biomedical Laboratory Science (IFBLS)	2018/09		Disclose to all
小児AMLにおけるG-CSFR isoform IV発現解析	小児AMLにおけるG-CSFR isoform IV発現解析	第13回京都地区小児血液腫瘍研究会	第13回京都地区小児血液腫瘍研究会	2018/07		Disclose to all
Cell-autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells	Cell-autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells	59th ASH Annual Meeting & Exposition	59th ASH Annual Meeting & Exposition	2017/12		Disclose to all
RUNX cluster regulation by GENE SWITCH triggers a profound tumor regression of diverse origins	RUNX cluster regulation by GENE SWITCH triggers a profound tumor regression of diverse origins	第79回日本血液学会学術集会	第79回日本血液学会学術集会	2017/10		Disclose to all
特発性びまん性肺骨形成の1例	特発性びまん性肺骨形成の1例	平成29年度NPO夏季学術集会	平成29年度NPO夏季学術集会	2017/07		Disclose to all
Distribution of the driver mutations among blood cell compartments in MDS and AML	Distribution of the driver mutations among blood cell compartments in MDS and AML	第78回日本血液学会学術集会	第78回日本血液学会学術集会	2016/10		Disclose to all
Experience of the first certification of ISO15189:2012 in physiological examination in Japan	Experience of the first certification of ISO15189:2012 in physiological examination in Japan	The 32nd World Congress of Biomedical Laboratory Science (IFBLS)	The 32nd World Congress of Biomedical Laboratory Science (IFBLS)	2016/08		Disclose to all
法的脳死判定における脳波検査および聴性脳幹誘発電位検査の経験	法的脳死判定における脳波検査および聴性脳幹誘発電位検査の経験	平成28年度日臨技近畿支部医学検査学会	平成28年度日臨技近畿支部医学検査学会	2016/05		Disclose to all
Prognostic Significance of CXCR4 Overexpression in Pediatric Acute Myeloid Leukemia with Low-Risk: A Report from the Japanese Pediatric Leukemia/Lymphoma Study Group	Prognostic Significance of CXCR4 Overexpression in Pediatric Acute Myeloid Leukemia with Low-Risk: A Report from the Japanese Pediatric Leukemia/Lymphoma Study Group	57th ASH Annual Meeting and Exposition	57th ASH Annual Meeting and Exposition	2015/12		Disclose to all
Investigation of new cell surface markers in acute myeloid leukemia using multi-color flow cytometry	Investigation of new cell surface markers in acute myeloid leukemia using multi-color flow cytometry	第77回日本血液学会学術集会	第77回日本血液学会学術集会	2015/10		Disclose to all
Prognostic significance of CXCR4 overexpression in pediatric AML: the JPLSG AML-05 study	Prognostic significance of CXCR4 overexpression in pediatric AML: the JPLSG AML-05 study	第77回日本血液学会学術集会	第77回日本血液学会学術集会	2015/10		Disclose to all
ISO15189：2012 生理学的分野の拡大審査認定取得概要と今後の展望	ISO15189：2012 生理学的分野の拡大審査認定取得概要と今後の展望	第58回日本臨床検査医学会近畿支部総会	第58回日本臨床検査医学会近畿支部総会	2015/10		Disclose to all
世界の医療をリードする臨床検査技師を目指して	世界の医療をリードする臨床検査技師を目指して	第64回日本医学検査学会	第64回日本医学検査学会	2015/05	Symposium workshop panel(nominated)	Disclose to all
A novel method to investigate prognostic factors by purifying leukemic blast cells from blood smears	A novel method to investigate prognostic factors by purifying leukemic blast cells from blood smears	The 31st World Congress of Biomedical Laboratory Science (IFBLS)	The 31st World Congress of Biomedical Laboratory Science (IFBLS)	2014/10		Disclose to all
好中球の殺菌能におけるオートファジー機構の役割	好中球の殺菌能におけるオートファジー機構の役割	第25回日本生体防御学会学術総会	第25回日本生体防御学会学術総会	2014/07		Disclose to all
レーザーマイクロダイセクションを用いてスメア標本より純化した白血病細胞を用いた小児AMLの新規予後因子探索	レーザーマイクロダイセクションを用いてスメア標本より純化した白血病細胞を用いた小児AMLの新規予後因子探索	平成26 年度第1 回合同班会議 JPLSG 総会・研究会	平成26 年度第1 回合同班会議 JPLSG 総会・研究会	2014/06		Disclose to all
THE PROGNOSTIC RELEVANCE OF THE 2008 WHO CLASSIFICATION OF MYELOID NEOPLASMS IN CHILDHOOD ACUTE MYELOID LEUKEMIA	THE PROGNOSTIC RELEVANCE OF THE 2008 WHO CLASSIFICATION OF MYELOID NEOPLASMS IN CHILDHOOD ACUTE MYELOID LEUKEMIA	19th Congress of the European Hematology Association	19th Congress of the European Hematology Association	2014/06		Disclose to all
Investigation of the clinical significance of CEBPA mutation in child AML: the JPLSG AML-05 study	Investigation of the clinical significance of CEBPA mutation in child AML: the JPLSG AML-05 study	第75回日本血液学会学術集会	第75回日本血液学会学術集会	2013/10		Disclose to all
血液疾患の予後因子をスメア標本より検出するシステムの確立	血液疾患の予後因子をスメア標本より検出するシステムの確立	第8回日本臨床検査学教育学会	第8回日本臨床検査学教育学会	2013/08		Disclose to all
感染症治療における好中球の殺菌能の意義とオートファジーの役割について	感染症治療における好中球の殺菌能の意義とオートファジーの役割について	第22回日本Cell Death学会	第22回日本Cell Death学会	2013/07		Disclose to all
免疫グロブリン製剤による多剤耐性菌に対する好中球の殺菌能増強効果～移植後免疫抑制患者における検討～	免疫グロブリン製剤による多剤耐性菌に対する好中球の殺菌能増強効果～移植後免疫抑制患者における検討～	第87回日本感染症学会総会学術集会	第87回日本感染症学会総会学術集会	2013/06		Disclose to all
AML-D11付随研究：ダウン症候群に合併した急性骨髄性白血病(AML-DS)の新規予後因子探索	AML-D11付随研究：ダウン症候群に合併した急性骨髄性白血病(AML-DS)の新規予後因子探索	平成25年度第1回JPLSG全体会議・合同班会議	平成25年度第1回JPLSG全体会議・合同班会議	2013/06		Disclose to all
AMLおよびMDSの新規予後因子探索プロジェクトについて	AMLおよびMDSの新規予後因子探索プロジェクトについて	平成24年度第2回JPLSG全体会議・合同班会議	平成24年度第2回JPLSG全体会議・合同班会議	2012/11		Disclose to all
免疫グロブリン製剤による貪食刺激好中球のオートファジー増強とその役割	免疫グロブリン製剤による貪食刺激好中球のオートファジー増強とその役割	第21回日本Cell Death学会	第21回日本Cell Death学会	2012/07		Disclose to all
好中球のオートファジーを介した多剤耐性菌殺菌機構と免疫グロブリン製剤による増強作用	好中球のオートファジーを介した多剤耐性菌殺菌機構と免疫グロブリン製剤による増強作用	第86 回日本感染症学会総会学術集会	第86 回日本感染症学会総会学術集会	2012/04		Disclose to all
免疫グロブリン製剤による多剤耐性菌に対する好中球殺菌増強作用	免疫グロブリン製剤による多剤耐性菌に対する好中球殺菌増強作用	第85回日本感染症学会総会学術集会	第85回日本感染症学会総会学術集会	2011/04		Disclose to all
<< < > >> Title language:

Newspaper articles

Title	Media name	Column name	Date
乳がん薬白血病抑える　京大、細胞実験で確認	日本経済新聞	朝刊42面	2018/11/01
白血病、既存の乳がん薬が効果　京大が遺伝子変異特定	日経電子版	https://r.nikkei.com/article/DGXMZO37173800R31C18A0000000?s=3	2018/11/01

External funds: competitive funds and Grants-in-Aid for Scientific Research (Kakenhi)

Type	Position	Title(Japanese)	Title(English)	Period
科研費　若手研究(B)	Representative	白血病細胞純化システムを用いた急性骨髄性白血病の新規予後因子探索		2016/04/01-2019/03/31
科研費　若手研究	Representative	小児急性骨髄性白血病におけるD型サイクリン遺伝子異常の解明と新規治療法開発		2019/04/01-2023/03/31

External funds: other than those above

System	Main person	Title(Japanese)	Period
公益財団法人黒住医学研究振興財団第25回研究助成金	松尾英将	正常核型急性骨髄性白血病における新規予後因子探索	2017/11/01-2018/10/31
日本血液学会 2017年度研究助成金	松尾英将	小児MLL再構成AMLにおける新規遺伝子変異の機能解析および新規治療法開発	2017/04/01-2018/03/31
公益信託日本白血病研究基金助成金	松尾英将	小児急性骨髄性白血病におけるD-type Cyclin遺伝子の3’ UTR構造異常の解明	2018/10/27-2019/09/30
日本血液学会 2018年度研究助成金	松尾英将	網羅的遺伝子解析により同定したt(8;21)AMLの新規遺伝子変異をターゲットとした治療法開発	2018/04/01-2019/03/31
日本血液学会 2019年度研究助成金	松尾英将	血液腫瘍疾患のクローン構造解明に寄与する新規シングルセル解析法の確立	2019/04/01-2020/03/31

Other research activities

Title	Location	Misc	Period
客員研究員	名古屋医療センター		2017/06/01-
拠点研究員	東京大学医科学研究所		2019/04/01-

Teaching subject(s)

Name(Japanese)	Name(English)	Term	Department	Period
血液検査学実習	Practice of Hematological Laboratory Medicine	前期	医学部（人間健康科学科）	2018/04/01-2019/03/31
臨床検査総論実習	Practice of General Clinical Laboratory	前期	医学部（人間健康科学科）	2018/04/01-2019/03/31
病態生理学	Pathophysiology	前期	医学研究科（人間健康科学系専攻）	2018/04/01-2019/03/31
臨床生理・超音波診断学実習	Practice of Clinical Physiology and Diagnosis by Ultrasonogr	後期	医学部（人間健康科学科）	2018/04/01-2019/03/31
人間健康科学IV	Introduction to Human Health Sciences IV	後期	医学部（人間健康科学科）	2018/04/01-2019/03/31
生体応答解析学実習	Practice of Biological Response Analysis	後期	医学部（人間健康科学科）	2018/04/01-2019/03/31
免疫学実習	Immunology training	後期	医学部（人間健康科学科）	2018/04/01-2019/03/31
臨床病態情報解析学演習	Practice of Informative Clinical Medicine	後期	医学部（人間健康科学科）	2018/04/01-2019/03/31
免疫学実習	Immunology training	後期	医学部（人間健康科学科）	2019/04-2020/03
病態生理学	Pathophysiology	前期	医学研究科（人間健康科学系専攻）	2019/04-2020/03
臨床生理・超音波診断学実習	Practice of Clinical Physiology and Diagnosis by Ultrasonogr	後期前半	医学部（人間健康科学科）	2019/04-2020/03
臨床病態情報解析学演習	Practice of Informative Clinical Medicine	後期	医学部（人間健康科学科）	2019/04-2020/03
血液学実習	Practice of Hematology	前期	医学部（人間健康科学科）	2019/04/-2020/03/
臨床検査総論実習	Practice of General Clinical Laboratory	前期	医学部（人間健康科学科）	2019/04/-2020/03/
病態生理学	Pathophysiology	前期	医学研究科（人間健康科学系専攻）	2020/04-2021/03
臨床実習	Learning Clinical Laboratory Medicine in Hospital	後期	医学部（人間健康科学科）	2020/04-2021/03
臨床検査総論実習	Practice of General Clinical Laboratory	前期	医学部（人間健康科学科）	2020/04-2021/03
臨床生理・超音波診断学実習	Practice of Clinical Physiology and Diagnosis by Ultrasonogr	後期前半	医学部（人間健康科学科）	2020/04-2021/03
血液学実習	Practice of Hematology	前期	医学部（人間健康科学科）	2020/04-2021/03
<< < > >>

Faculty management (title, position)

Title	Period
多職種教育・合同教育TF	2018/04/01-2019/03/31

Academic organizaions (conference administrator)

Organization name	Group name	Title	Period
世界医学検査学会	第32回世界医学検査学会	国際学生フォーラム実務委員	2016/08/31-2016/09/04

Other activities (awards)

Award name	Organization name	Date
Abstract Achievement Award	米国血液学会	2015/10/24
京都大学総長賞	京都大学	2016/03/14
日臨技学生表彰会長賞	日本臨床衛生検査技師会	2018/02/22
若手一般研究賞	日本白血病研究基金	2018/10/27

Other activities (primary and secondary education)

Title	Activity	School	Prefecture	Date
職業体験	京大病院検査部見学対応	立命館中学校	京都府	2019/11/20
研究室訪問	京大病院検査部見学対応	東山中学校	京都府	2019/11/11
職業体験	京大病院検査部見学対応	立命館中学校	京都府	2018/11/21
研究室訪問	研究室・京大病院検査部見学対応	滝高校	愛知県	2018/08/06

松尾 英将

松尾英将